Elexacaftor/Tezacaftor/Ivacaftor Accelerates Wound Repair in Cystic Fibrosis Airway Epithelium

Background: Cystic fibrosis (CF) airway epithelium shows alterations in repair following damage. In vitro studies showed that lumacaftor/ivacaftor (Orkambi) may favor airway epithelial integrity in CF patients. Our aim was to evaluate the effect of the novel triple combination elexacaftor/tezacaftor...

Descripción completa

Detalles Bibliográficos
Autores principales: Laselva, Onofrio, Conese, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605106/
https://www.ncbi.nlm.nih.gov/pubmed/36294716
http://dx.doi.org/10.3390/jpm12101577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605106/
https://www.ncbi.nlm.nih.gov/pubmed/36294716
http://dx.doi.org/10.3390/jpm12101577

Ejemplares similares